Depression and ischemic heart disease: what have we learned from clinical trials?
- 1 July 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Cardiology
- Vol. 22 (4), 286-291
- https://doi.org/10.1097/hco.0b013e3281ead011
Abstract
Discuss the interplay of depression and ischemic heart disease. Studies demonstrate high prevalence of depression and its negative impact among patients with ischemic heart disease. Results extend previous findings among men, demonstrating a significant increase in mortality and cardiovascular events among depressed women. Sertraline, citalopram and mitrazapine have been shown to be safe and well tolerated in patients with ischemic heart disease. Sertraline and citalopram have demonstrated efficacy for treating depression in such patients. Mirtazapine did not have significant efficacy on post-myocardial infarction depression. Cognitive-behavioral therapy and interpersonal therapy have not been found to have a significant treatment effect. Treating depression may have an impact on cardiovascular morbidity and mortality, but this has not yet been adequately studied. Studies to date lack sufficient statistical power to fully examine the impact of interventions for depression on cardiovascular outcomes. Cardiologists encounter depression among 25-30% of their patients with ischemic heart disease. Depression is an independent risk factor for poor prognosis among ischemic heart disease patients, at a level comparable to several conventional cardiac risk factors. Adequate treatment of depression may improve the poor prognosis of depressed patients with ischemic heart disease.Keywords
This publication has 47 references indexed in Scilit:
- Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery DiseaseJAMA, 2007
- The prevalence of unrecognized depression in patients with acute coronary syndromeAmerican Heart Journal, 2006
- Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-ITEuropean Heart Journal, 2005
- Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk StudyEuropean Heart Journal, 2000
- Treating Depression in Patients with Ischaemic Heart DiseaseDrug Safety, 1999
- Cardiovascular Events and Mortality in Newly and Chronically Depressed Persons >70 Years of AgeThe American Journal of Cardiology, 1998
- Depression and Long-Term Mortality Risk in Patients With Coronary Artery DiseaseThe American Journal of Cardiology, 1996
- Depression and 18-Month Prognosis After Myocardial InfarctionJournal of Cardiopulmonary Rehabilitation, 1995
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Major depressive disorder in coronary artery diseaseThe American Journal of Cardiology, 1987